Aeolus Pharmaceuticals, Inc.

Aeolus Pharmaceuticals, Inc.verified

AOLS

Price:

$0.0003

Market Cap:

$45.63K

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicant...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1996-02-02

Stock Exchange

PNK

Ticker

AOLS

The PE Ratio as of December 2024 (TTM) for Aeolus Pharmaceuticals, Inc. (AOLS) is -0.03

According to Aeolus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -99.42% compared to the average of -5.21 of the last 4 quarters.

Aeolus Pharmaceuticals, Inc. (AOLS) Historical PE Ratio (quarterly & annually)

How has AOLS PE Ratio performed in the past?

The mean historical PE Ratio of Aeolus Pharmaceuticals, Inc. over the last ten years is -43.71. The current -0.03 PE Ratio has changed -93.14% with respect to the historical average. Over the past ten years (40 quarters), AOLS's PE Ratio was at its highest in in the June 2014 quarter at 7.68. The PE Ratio was at its lowest in in the March 2014 quarter at -19.55.

Quarterly (TTM)
Annual

Average

-43.71

Median

0

Minimum

-420.83

Maximum

13.42

Aeolus Pharmaceuticals, Inc. (AOLS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aeolus Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 13.42

Minimum Annual Increase = 0%

Minimum Annual PE Ratio = -420.83

Quarterly (TTM)
Annual
YearPE RatioChange
202300%
202200%
202100%
202000%
20190-100.00%
2016-7.94-36.18%
2015-12.44-97.04%
2014-420.834.42%
2013-9.30-169.29%
201213.42-83.93%

Aeolus Pharmaceuticals, Inc. (AOLS) Average PE Ratio

How has AOLS PE Ratio performed in the past?

The current PE Ratio of Aeolus Pharmaceuticals, Inc. (AOLS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

0

5-year avg

0

10-year avg

-43.71

Aeolus Pharmaceuticals, Inc. (AOLS) PE Ratio vs. Peers

How is AOLS’s PE Ratio compared to its peers?

Aeolus Pharmaceuticals, Inc.’s PE Ratio is less than Amexdrug Corporation (4.30), greater than Aion Therapeutic Inc. (-0.71), less than Aspen Pharmacare Holdings Limited (9.41), greater than Antisense Therapeutics Limited (-3.23), greater than Alterola Biotech, Inc. (-2.85), greater than The BC Bud Corporation (-5.76), greater than Crescita Therapeutics Inc. (-3.94), greater than AusCann Group Holdings Ltd (-2.17),

Build a custom stock screener for Aeolus Pharmaceuticals, Inc. (AOLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeolus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aeolus Pharmaceuticals, Inc. (AOLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aeolus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Aeolus Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Aeolus Pharmaceuticals, Inc. (AOLS)?

What is the highest PE Ratio for Aeolus Pharmaceuticals, Inc. (AOLS)?

What is the 3-year average PE Ratio for Aeolus Pharmaceuticals, Inc. (AOLS)?

What is the 5-year average PE Ratio for Aeolus Pharmaceuticals, Inc. (AOLS)?

How does the current PE Ratio for Aeolus Pharmaceuticals, Inc. (AOLS) compare to its historical average?